Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monoclonal antibodies
Research
18 years of self-inflicted snakebites lead to new antivenom
Antibodies from a man who has been slowly building snake venom immunity led to a cocktail that saved mice from 13 of the world's deadliest snakes.
Darren Incorvaia
May 2, 2025 2:10pm
FDA plans to end animal testing for new monoclonal antibody INDs
Apr 11, 2025 1:22pm
Ikena, after tough year of layoffs, merges with Inmagene
Dec 23, 2024 10:00am
Pyxis whittles pipeline down to one clinical asset
Dec 20, 2024 6:15am
Genmab buys 2nd antibody from Scancell in deal worth up to $630M
Dec 4, 2024 11:55am
Roivant’s midstage asset fails to show benefit in lung disease
Dec 3, 2024 10:32am